APP and early-onset autosomal dominant Alzheimer disease: In APP/PS1 transgenic mice as a model of Alzheimer’s disease, lotus seedpod PACs administered for 5 months improved cognitive dysfunction and long-term potentiation through the stimulation of the CREB–BDNF pathway (Wang et al., 2023).